Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Recro Pharma Company Profile (NASDAQ:REPH)

Consensus Ratings for Recro Pharma (NASDAQ:REPH) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $33.00 (454.62% upside)

Analysts' Ratings History for Recro Pharma (NASDAQ:REPH)
Show:
DateFirmActionRatingPrice TargetDetailsShare
6/12/2014AegisInitiated CoverageBuy$40.00ViewTweet This Rating  Share This Rating on StockTwits
3/19/2014Brean CapitalInitiated CoverageBuy$26.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/30/2012 forward)